COMMUNIQUÉS West-GlobeNewswire
-
Galecto Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
10/02/2026 -
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
10/02/2026 -
The Cooperative of American Physicians Announces Continued A+ (Superior) Rating for the Mutual Protection Trust
10/02/2026 -
PetVivo Issues Correction and Replacement Press Release; Sets Fiscal Third Quarter 2026 Conference Call for Tuesday, February 17, 2026 at 5:00 p.m. ET
10/02/2026 -
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
10/02/2026 -
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
10/02/2026 -
Galapagos Receives Transparency Notifications from Bank of America
10/02/2026 -
DBV Technologies présentera des données complémentaires issues de l'étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans et discutera de l'avenir de l'EPIT lors du congrès annuel 2026 de l'AAAAI
10/02/2026 -
PharmAla Announces Changes to Board of Directors
10/02/2026 -
Vaxcyte to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on February 24, 2026
10/02/2026 -
Nebraska Remains a National Outlier in Certified Nurse-Midwife Regulation
10/02/2026 -
Miami Startup Launches First At-Home Gut Test Designed Specifically for Cognitive Wellness
10/02/2026 -
Newsweek Names Chicago Plastic Surgeons Best in America for 11 Procedures
10/02/2026 -
Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation
10/02/2026 -
Press Release: Sanofi completes the acquisition of Dynavax
10/02/2026 -
Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
10/02/2026 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
10/02/2026 -
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2026
10/02/2026 -
IBA – ACQUISITION OF OWN SHARES
10/02/2026
Pages